baber/WOPTO huggingface dataset:
Patent PT-1313440-E (PT)
Title: Dental products comprising bone growth enhancing peptide
Inventor: YONEDA TOSHIYUKI
IPC: A61Q11/00
Filed: 2001-08-09
Abstract: Dental products such as toothpastes, mouthwash and dental floss are disclosed which products are enhanced by having dissolved, dispersed or coated thereon a compound which promotes bone growth. Preferred compounds are peptide sequences comprising 10 to 50 amino acids are disclosed. The sequences are characterized by containing an integrin binding motif such as RGD sequence and the remainder of amino acids contiguous with the RGD sequence in matrix extracellular phosphoglycoprotein. The sequences may be formulated for dispersed in toothpaste or a mouthwash and administered to enhance bone/tooth growth. When the dental products are used repeatedly over time they enhance good dental health.
Patent PT-1334661-E (PT)
Title: Ectoparasitic insect pest controllers for animals and their usage
Inventor: YAMAGUTI RIKIO
IPC: A01N47/40
Filed: 2001-10-16
Abstract: <CHEM>   <CHEM>   Ectoparasitic insect pest controllers for animals, containing hydrazine derivatives of the general formula (I) as the active ingredient, and methods for application of the same: (I) Äwherein A is (II), (III), (IV), (V) (wherein R<4> and R<5> are each H, C1- 6 alkyl, or the like; and X is H, or one to five substituents selected from among halogeno and optionally halogenated C1-6 alkyl groups); R<1> is H or C1-6 alkyl; R<2> and R<3> are each H, OH, C1-6 alkyl, phenylcarbonyl, or the like; Y is H, or one to five substituents selected from among halogeno, nitro, and cyano; Z is halogeno, cyano, C1-6 alkyl, or the like; and W is O or SÜ. The insect pest controllers exert remarkable controlling effects on parasitic insect pests harmful to domestic or pet animals, e.g. fleas, lice, ticks.
Patent PT-1384477-E (PT)
Inventor: CUBERES-ALTISENT MARIA ROSA
IPC: A61P35/04
Filed: 2002-03-21
Abstract: Derivatives of pyrazoline (I), wherein R1 is hydrogen, methyl, fluoromethyl, difluoromethyl, trifluoromethyl, carboxylic acid, alkyl carboxylate with 1 to 4 carbon atoms, carboxamide or cyano, R2 is hydrogen or methyl, R3, R4, R7 and R8, independently are hydrogen, chlorine, fluorine, methyl, trifluoromethyl or methoxy, R5 and R6, independently, are hydrogen, chlorine, fluorine, methyl, trifluoromethyl, methoxy, trifluoromethoxy, methylsulphonyl, aminosulphonyl or acetylaminosulphonyl, with the condition that one of the substituents R5 or R6 is a methylsulphonyl, aminosulphonyl or acetylaminosulphonyl group, and with the condition that when R1 is methyl, then R2 is hydrogen or methyl, R3 and R8, independently are hydrogen, chlorine, fluorine, methyl, or trifluoromethyl, R4 is hydrogen, , fluorine, methyl, trifluoromethyl or methoxy, R5 is fluorine, trifluoromethyl, trifluoromethoxy, methylsulphonyl, aminosulphonyl or acetylaminosulphonyl, R6 is hydrogen, chlorine, fluorine, methyl, trifluoromethyl, methoxy, trifluoromethoxy, methylsulphonyl, aminosulphonyl or acetylaminosulphonyl, with the condition that one of the substituents R5 or R6 is a methylsulphonyl, aminosulphonyl or acetylaminosulphonyl group, and R7 represents an atom of hydrogen, chlorine, fluorine, a methyl, trifluoromethyl or methoxy group; useful for preventing or treating cell proliferation diseases.
Patent PT-1412354-E (PT)
Inventor: GIORGIO TARZIA
IPC: A61P25/28
Filed: 2002-07-25
Abstract: Compounds of formula (I) wherein: X is CH or CH-R2; R1 is C1-C6 linear or branched alkyl or C1-C6 linear or branched alkenyl; R2 is hydrogen, C1-C6 linear or branched alkyl or C1-C6 linear or branched alkenyl, C6-C14 aryl or C6-C14 aryl(C1-C6) linear or branched alkyl or C6-C14 aryl(C1-C6) linear or branched alkenyl, with the aryl group optionally substituted by one or more substituents, either the same or different, selected from the group consisting of halogen, hydroxy, C1-C6 alkoxy linear or branched or C1-C6 alkenyloxy linear or branched, amino, optionally mono- or disubstituted with C1-C6 linear or branched alkyl; R3 is NH2, or NHR4; R4 is C1-C6 alkyl or C1-C6 hydroxyalkyl, C1-C3 alkoxyalkyl, amino(C1-C6)alkyl, where the amino group is optionally substituted with one or two C1-C3 linear or branched alkyl groups, or with one or two C2-C3 alkenyl groups C6-C14 aryl or C6-C14 aryl(C1-C6)alkyl, with the aryl group optionally substituted by one or more substituents, either the same or different, selected from the group consisting by halogen, hydroxy, C1-C6 alkoxy linear or branched or C1-C6 alkenyloxy linear or branched, amino, mono- or di-substituted with C1-C6 alkyl linear or branched or C1-C6 alkenyl linear or branched; and their pharmaceutically acceptable salts. These compounds are antagonists of the adenosine A2a receptor and useful as medicaments, in particular for the treatment of Parkinson's disease.
Patent PT-1433207-E (PT)
Title: A process for large-scale production of cdte/cds thin film solar cells
Inventor: ROMEO NICOLA
IPC: H01L31/073
Filed: 2002-10-04
Abstract: A process for large-scale production of CdTe/CdS thin film solar cells, films of the cells being deposited, in sequence, on a transparent substrate, the sequence comprising the steps of: depositing a film of a transparent conductive oxide (TCO) on the substrate; depositing a film of CdS on the TCO film; depositing a film of CdTe on the CdS film; treating the CdTe film with CdCl<SUB>2</SUB>; depositing a back-contact film on the treated CdTe film. Treatment of the CdTe film with CdCl<SUB>2 </SUB>comprises the steps of: forming a layer of CdCl<SUB>2 </SUB>on the CdTe film by evaporation, while maintaining the substrate at room temperature; annealing the CdCl<SUB>2 </SUB>layer in a vacuum chamber at a temperature generally within a range of 380° C. and 420° C. and a pressure generally within a range of 300 mbar and 1000 mbar in an inert gas atmosphere; removing the inert gas from the chamber so as to produce a vacuum condition, while the substrate is kept at a temperature generally within a range of 350° C. and 420° C. whereby any residual CdCl<SUB>2 </SUB>is evaporated from the CdTe film surface.
Patent PT-1407935-E (PT)
Inventor: WOLFGANG SCHABEL
IPC: C23C30/00
Filed: 2003-08-30
Abstract: Motor vehicle component, especially an external component, e.g. a decorative object, made of aluminum, especially polished or anodized aluminum, is provided at least partly with a thin ceramic coating (2).  An Independent claim is also included for a motor vehicle provided with the motor vehicle component. Preferred Features: The thin ceramic coating is an electrical conductor and has a thickness of 5-10, especially 5-7 microns.
Patent PT-1515626-E (PT)
Title: Method for manufacturing articles of jewellery
Inventor: CERATO SILVERIO
IPC: A44C27/00
Filed: 2003-12-02
Abstract: Method for manufacturing an article of jewellery, which comprises a step involving manufacture of a first hollow element in tubular form, said element being made of precious metal or a precious metal alloy and intended to act as a lining; a step involving preparation of a second element in cylindrical form made of metal or metal alloy and intended to act as a core for said first element in tubular form; a step involving coaxial combining together of the two elements by interposing a layer of solder in between so as to obtain a tubular assembly which is then subject to a first drawing step aimed at compressing the first element onto the second element; this is then followed by a step involving brazing of the tubular assembly so as to melt the layer of solder and fix together the two elements before a second drawing step for reducing the thickness of the brazed tubular assembly to the desired value.
Patent PT-1502544-E (PT)
Title: Detection of metal disturbance in a magnetic tracking system
Inventor: GOVARI ASSAF
IPC: G01S5/04
Filed: 2004-07-30
Abstract: A method for tracking an object includes producing energy fields at a plurality of different frequencies in a vicinity of the object, and receiving signals that are generated at a location of the object at the different frequencies in response to the energy fields. Multiple computations are made of spatial coordinates of the object based on the signals received at the different frequencies. Convergence of the computations is tested in order to ascertain whether the energy fields have been perturbed by an article in the vicinity of the object. <IMAGE>
Patent PT-1793684-E (PT)
Title: Process for preserving fresh produce and coating composition therefor
Inventor: PETCAVICH ROBERT J
IPC: A23L17/40
Filed: 2004-07-02
Abstract: The present invention provides compositions and methods for extending the shelf-life of fresh produce. The method comprises coating the exterior surface of the produce with a coating composition comprising an aqueous solution of from about to about 3 percent by weight of a chitosan or modified chitosan, from about 0.1 to percent by weight of an organic acid, from about 0.02 to about 0.1 percent by weight of a surfactant, and optionally plants growth regulators, antimicrobials, plasticizers and antifoaming agents.
Patent PT-1647342-E (PT)
Title: Barbed-type mesh
Inventor: GARCIA JUAN MARIA CRUZ-SAGREDO
IPC: A01G13/10
Filed: 2004-06-30
Abstract: The invention relates to a barbed-type mesh which is primarily intended to be used to protect young trees from livestock or other animals. The inventive mesh is made from wires or electrowelded bars which form polygons having sharp points on the surface thereof. Said sharp points are connected to the mesh during the production method thereof or by means of braiding.
Patent PT-1691741-E (PT)
Title: Apparatuses for altering relative curvature of field and positions of peripheral, off-axis focal positions
Inventor: SMITH EARL LEO
IPC: A61F9/01
Filed: 2004-07-09
Abstract: A method and apparatus are disclosed for controlling optical aberrations to alter relative curvature of field by providing ocular apparatuses, systems and methods comprising a predetermined corrective factor to produce at least one substantially corrective stimulus for repositioning peripheral, off-axis, focal points relative to the central, on-axis or axial focal point while maintaining the positioning of the central, on-axis or axial focal point on the retina. The invention will be used to provide continuous, useful clear visual images while simultaneously retarding or abating the progression of myopia or hypermetropia.
Patent PT-1704340-E (PT)
Title: Coupling with direct transmission of the rotational movement of an actuation bolt to a clamping jaw driven in translation by the latter
Inventor: DEVEHAT RENAUD LE
IPC: F16L23/036
Filed: 2004-12-23
Abstract: A coupling for securing a first element to a second element includes an actuation bolt, a clamping jaw mounted on the first element which comprises a bore having a threaded part which defines a nut that threadedly engages the actuation bolt, and a torque limitation device positioned between the actuation bolt and the bore for transmitting the rotational movement of the actuation bolt directly to the clamping jaw to thereby rotate the clamping jaw about the axis. In operation, when an external force acting on the clamping jaw is greater that the force generated against the bore by the torque limitation device, rotation of the actuation bolt will result in translation of the clamping jaw, and when the external force acting on the clamping jaw is less than the force generated against the bore by the torque limitation device, rotation of the actuation bolt will rotate the clamping jaw about the axis.
Patent PT-1684719-E (PT)
Title: Alpha 1-antitrypsin compositions and treatment methods using such compositions
Inventor: DURRANI MANZER J
IPC: A61K9/00
Filed: 2004-11-11
Abstract: Alpha 1-antitrypsin compositions and treatment methods using such compositions for treating a variety of pulmonary diseases are provided. The compositions generally contain AAT, a stabilizing carbohydrate such as trehalose, a surfactant such as Polysorbate 80 and an antioxidant to stabilize AAT for use as a therapeutic. The formulations can be prepared as both liquids and solids and administered by nebulization of the liquid formulation or by conversion of dry powder formulation into an aerosol.
Patent PT-1719067-E (PT)
Title: Method for the operation of rfid read/write devices
Inventor: KUENG ROLAND
IPC: G06K7/00
Filed: 2005-07-21
Abstract: A method of operating a first RFID read/write device and at least one second RFID read/write device is disclosed herein. The first and second RFID read/write devices respectively comprise an RF part and a baseband part with a digital signal processor. The first and second RFID read/write devices are arranged at a usable wireless transmission distance from one another. The method comprises generating a Reader Service Signal in its baseband form in the signal processor and combining the Reader Service Signal with an RFID signal in its baseband form comprising a carrier signal, so that the RFID signal has the Reader Service Signal embedded to it in amplitude, frequency or phase. Thereafter, the RFID signal with the embedded Reader Service Signal is shifted into an RF band and the RFID signal is transmitted as a transmission signal wirelessly by the RFID read/write devices. The transmission signal from the first RFID read/write device is received by a number of electronic tags for the purpose of communicating with the first RFID read/write device. Simultaneously, the transmission signal from the first RFID read/write device is received at least by the one second RFID read/write device for the purpose of communicating with the first RFID read/write device.
Patent PT-1789336-E (PT)
Title: Sealing means for a closure, closure and process
Inventor: DRUITT RODNEY
IPC: B65D41/04
Filed: 2005-08-02
Abstract: The present invention is directed to a sealing means (2) for sealing of a neck (25) of a container, especially a container for carbonated beverages. The sealing means comprises a radially deformable outer sealing means (20) suitable to be engaged with an outer free surface (17) of a neck (25) of the container. The outer sealing means (20) comprises an annular base (22) which blends by a blend (34) into a vertical top surface (35) and at least one annular sealing ring (23) arranged at a free end of the annular base (22), protruding radially inwardly above the inner surface of the base (22) and forming in engaged position with the neck (25) a first contact area (30) with the outer free surface (17).
Patent PT-1782845-E (PT)
Title: Bone cement and x-ray contrast agent and methods of manufacturing the same
Inventor: KUEHN KLAUS-DIETER
IPC: A61K6/884
Filed: 2003-04-25
Abstract: Bone cement mixture comprises a polymer component containing a X-ray contrast agent and a monomer component, where the X-ray contrast agent is present as essentially spherical polymer or copolymer particles with dispersed X-ray opaque inorganic nano-particles with a particle size of 3-15 nm, manufactured by suspension polymerization in the presence of nano-particles, where the nano-particles are covered completely by the copolymer material, and the inorganic nano-particles consist essentially of zirconium oxide. Independent claims are included for: (1) the X-ray contrast agent; and (2) a method for the production of the X-ray contrast agent, comprising polymerizing zirconyl-dimethacrylate and/or other zirconium and/or methacrylate containing other X-ray opaque elements to form a polymer or a copolymer.
Patent PT-2065432-E (PT)
Title: Polyolefin microporous membrane and separator for nonaqueous electrolyte battery
Inventor: HATAYAMA HIROSHI
IPC: H01M50/417
Filed: 2007-09-18
Abstract: The present invention provides a polyolefin microporous membrane made of a polyolefin resin and an inorganic particle, and the puncture strength of the microporous membrane is 3 N/20 µm or more and the membrane thickness retention ratio in penetration creep is 16% or more, thereby being excellent in safety and long-term reliability, and a separator for a nonaqueous electrolyte battery, and the like can be provided.
Patent PT-2410922-E (PT)
Title: Apparatus for carrying out diagnostic and/or therapeutic procedures
Inventor: MCENEANEY DAVID
IPC: A61B8/12
Filed: 2010-03-10
Abstract: An apparatus for carrying out diagnostic and/or therapeutic procedures and/or diagnosis, said apparatus comprising a hollow tubular catheter for insertion into the venous or arterial system or other body cavity of a patient, said catheter having a tip, an imaging device being associated with the tip of the catheter, said imaging device being adapted to provide an image of the tissue ahead of and lateral to the catheter tip, wherein the imaging device is provided at a distal end of an elongate guide member guided within a guide passage to be axially translatable within the guide passage, a portion of the guide passage at or adjacent the tip of the catheter extending in a substantially helical and/or circumferential configuration around a distal region of the catheter whereby the imaging device can be reciprocated around the tip of the catheter to produce a toroidal or substantially toroidal image of the tissue immediately around and ahead of the catheter tip.
Patent PT-2436275-E (PT)
Title: Lipid composition for improving brain function
Inventor: HAGEMAN ROBERT JOHAN JOSEPH
IPC: A23L33/00
Filed: 2008-06-20
Abstract: The invention pertains to the use of a lipid fraction for the support of brain function. The lipid fraction comprises the medium-chain fatty acids at least 4 g hexanoic acid and/or at least 5 g octanoic acid, at least 1 g eicosapentaenoic acid, and in addition more than 0.4 g ±-linolenic acid per 100 g fatty acids of the lipid fraction.
Patent PT-613262-E (PT)
Inventor: BRINK ROBERTUS FRANCISUS MARIA
IPC: H04B10/43
Filed: 1994-01-28
Abstract: Known optical noise sources are equipped with a light source and an interference filter, optically coupled thereto and based on path length difference, for generating an optical composition signal. If the spectrum of a photodiode to be illuminated with the optical composition signal is to be as flat as possible, said path length difference must be considerably greater than the coherence length of the light source which in present practice leads to disadvantageously large path length differences. By feeding, according to the invention, a noise signal to the light source, the coherence length of the light source decreases, as a result of which it is sufficient to use considerably smaller path length differences. <IMAGE>
Patent PT-932367-E (PT)
Inventor: MICHELSON GARY KARLIN
IPC: A61B17/16
Filed: 1996-05-30
Abstract: A system and method for anterior fixation of the spine utilizes a cylindrical implant engaged in the intradiscal space at the cephalad and caudal ends of the construct. The implants are cylindrical fusion devices (10) filled with bone material to promote bone ingrowth and fusion of the disc space. An attachment member (40) is connected to each of the fusion devices (10) and bone screws (30) having similar attachment members (33) are engaged in the vertebral bodies of the intermediate vertebrae. A spinal rod (50) is connected to each of the attachment members using an eyebolt assembly (53, 54, 55). In a further inventive method, a revision of the construct is achieved by removing the fusion devices. Each fusion device is engaged by an elongated guide member (62) over which a cylindrical trephine (70) is advanced. The trephine (70) has an inner diameter larger than the diameter of the fusion implant and includes cutting teeth (72) for extracting a core (84) of bone material around the fusion implant. The trephine (70) and guide member (62) are removed along with the bone core (84) containing the fusion implant (10). The trephine (70) is also used to extract a bone dowel from a solid bone mass to be inserted into the space left by the removed bone core (84).
Patent PT-953132-E (PT)
Inventor: BAKKEN KNUT
IPC: F25B41/04
Filed: 1998-01-08
Abstract: PCT No. PCT/NO98/00004 Sec. 371 Date Jun. 30, 1999 Sec. 102(e) Date Jun. 30, 1999 PCT Filed Jan. 8, 1998 PCT Pub. No. WO98/30847 PCT Pub. Date Jul. 16, 1998A refrigeration system having a closed circulating circuit filled with a refrigerant which on evaporation expands and gives rise to an increase in pressure in the whole or in parts of the circulating circuit, and which at ambient temperature has a saturation pressure that is higher than the maximum working pressure in the refrigeration circuit. A refrigeration of this kind may, for example, be carbon dioxide. By allowing vaporized refrigerant to condense against the surface of the refrigerant in liquid phase, contained in a container that is insulated and has adapted size and adapted liquid level, the pressure in the circulating circuit can be maintained below the maximum working pressure of the refrigeration circuit. Thus undesirable build-up of pressure in the event of, e.g., a period of inoperation or breakdown, is prevented, and the circulating circuit of the refrigeration system can be designed and made for a pressure which is below the saturation pressure at ambient temperature of the refrigerant used, and the refrigeration system can be made using conventional or at least virtually conventional elements, whereby the total system costs are reduced considerably in relation to a total system which is built to withstand higher pressure, e.g., the saturation pressure at room temperature of the refrigerant. Starting up after, e.g., a period of inoperation or breakdown is secured with valves which provide a controlled fall in pressure in an insulated container after an increase in pressure in the same container exceeding the maximum working pressure of the circuits.
Patent PT-1075284-E (PT)
Inventor: MELLES GERRIT REINOLD JACOB
IPC: A61P41/00
Filed: 1999-05-07
Abstract: The invention relates to a method for performing retinal membrane removal, wherein a retinal membrane is stained using at least one vital dye. The invention further relates to a staining composition for use in said method.
Patent SG-38393-G (SG)
Title: Tricyclic compounds
IPC: C07C237/30
Filed: 1993-04-06
Abstract: The present invention provides a compound of formula (I)or a salt, ester or amide thereof: wherein R<sup>1</sup> is -CH<sub>2</sub>-CH<sub>2</sub>-, CH<sub>2</sub>-O- or -O-CH<sub>2</sub>-: R<sup>2</sup> and R<sup>3</sup> are the same or different and are each hydrogen, C<sub>1-4</sub> alkyl or taken together with the nitrogen comprise a nitrogen-containing heterocyclic ring having four to six ring members; R<sup>4</sup> is a single bond or a C<sub>1-7</sub> bivalent aliphatic hydrocarbon group may be joined to the aromatic ring system at the 2, 3. 8 or 9 positions; n is 0 to 3. processes for its preparation and intermediates therefor, pharmaceutical compositions containing it and its use in medicine.
Patent SG-56584-G (SG)
Title: Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine and pharmaceutical compositions thereof
IPC: C07C211/58
Filed: 1984-08-13
Abstract: Novel cis-isomeric derivatives of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine are useful as antidepressant agents. These novel compounds act to block the synaptosomal uptake of serotonin (5-hydroxy-tryptamine), thereby alleviating serotonin abnormalities at central receptor sites. The preferred embodiment is the enantiomer cis-(1S)-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthal enamine and its pharmaceutically acceptable acid addition salts.